Latest Cancer Immunotherapy News

Page 3 of 3

Imugene Raises A$20 Million to Accelerate Cancer Immunotherapy Trials

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Ada Torres

29 Jan 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026

Top